Search results for " modular" in Articles / App Notes
Article
Monitoring and Control of Inline Dilution Processes
According to Vermunt, this platform is modular and configurable, providing customers with the ability to select the features most advantageous to their processes and manufacturing strategies. For exam…
Article
What’s New in Upstream Technologies
The system features a modular, scalable, fixed-bed bioreactor for enhanced upstream processing of viral products, including viral vaccines, viral vectors, and oncolytic viruses. The low-footprint inte…
Article
The Good and Bad of Biosimilars
Biosimilars have been around for years, but the biopharma industry – as well as the healthcare community – has been slow to embrace them. Today, however, the competition is really beginning to heat …
Article
Advances in Engineering of Protein-Based APIs
“Ongoing IgG-based modular domain engineering and platform development in multispecifics present great potential to elicit synergistic activities, enhanced therapeutic index (efficacy, selectivity, no…
Article
A Plastic Pipeline for Commercial Bioprocessing?
Both facilities use modular cleanrooms and incorporate single-use technologies.
While few drug products are made in single-use plastics, “We intend to be there. We’ve got a number of successes …
Article
FDA Seeks to Enhance Manufacturing of Cell and Gene Therapies
Marks suggested that new manufacturing technology, such as partially automated closed systems and modular manufacturing facilities, could help address some of these difficulties. He cited a lack of ca…
Article
Biopharma Says It Has an Evolution in New Technologies and Processes
Cytiva introduced prefabricated, modular KUBio manufacturing units for the production of viral vector-based therapeutics including viral-vector based vaccines, oncolytic viruses, and gene and cell the…
Article
Leveraging Data for Better Biopharmaceutical Process Control
Over the next decade, plant modularization and new facility designs promise to move biopharm and small-molecule manufacturing closer to Industry 4.0 models.
References
1. F. F. Gouveia, “Chemo…
Article
Going Viral
The new KUBio BSL-2 solution for viral vector-based therapeutics, including oncolytic vaccines and cell and gene therapies allows manufacturers to quickly build a ready-to-run, prefabricated modular m…
Article
Making the Move to Continuous Chromatography
“More modular, plug-and-play equipment designs that can fit in seamlessly to different automation backbones would help accelerate that transition,” she observes.
Accelerating adoption
As with …